Abstract
Enlargement of the male breasts, termed gynecomastia, is a common problem. In adult men, the prevalence of gynecomastia increases with age, and it may result in both psychosocial and, less often, physical discomfort. Male breast enlargement may occur as a side effect of many medications; occasionally, gynecomastia is a clue to the presence of disease elsewhere in the body. This chapter will review the pathogenesis of gynecomastia, its investigation as a clinical problem, and current approaches to treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Nicolis GL, Modlinger RS, Gabrilove JL. A study of histopathology of human gynecomastia. J Clin Endocrinol Metab, 1971;32:173–178.
Sasano H, Kimura M, Shizawa S, Kimura N, Nagura H. Aromatase and steroid receptors in gynecomastia and male breast carcinoma: an immunohistochemical study. J Clin Endocrinol Metab 1996;81:3063–3067.
Santner SJ, Pauley RJ, Tait L, Kaseta J, Santen RJ. Aromatase activity and expression in breast cancer and benign breast tissue stromal cells. J Clin Endocrinol Metab 1997;82:200–208.
DiCarlo R, Muccioli G, Bellussi G, Lando D, Mussa A. Presence and characterization of prolactin receptors in human benign breast tumours. Eur J Cancer Clin Oncol 1984;20:635–638.
Griffin JE, Leshin M, Wilson JD. Androgen resistance syndromes. Am J Physiol 1982;243:E81-E87.
Castro-Magana M, Angulo M, Uy J. Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. N Engl J Med 1993;328:1297–1301.
Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, et al. Aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab 1998;83:1348–1357.
Nuttall FQ. Gynecomastia as a physical finding in normal men. J Clin Endocrinol Metab 1979;48:338–340.
Carlson HE. Gynecomastia. N Engl J Med 1980;303:795–799.
Niewoehner CB, Nuttall FQ. Gynecomastia in a hospitalized male population. Am J Med 1984;77: 633–638.
Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 1997;18:701–715.
Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, Viosca SP, Garza D. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 1990;71: 963–969.
Forest MG, Lecoq A, Saez JM. Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17α-hydroxyprogesterone, Δ4-androstenedione, estrone, and 17ß-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J Clin Endocrinol Metab 1979;49:284–291.
Scheike O, Visfeldt J, Petersen B. Male breast cancer. 3. Breast carcinoma in association with the Klinefelter syndrome. Acta Pathol Microbiol Scand 1973;81:352–358.
Sasco AJ, Lowenfels AB, Pasker-deJong P. Epidemiology of male breast cancer: a meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993;53: 538–549.
Gabrilove JL, Nicolis GL, Mitty HA, Sohval AR. Feminizing interstitial cell tumor of the testis: personal observations and a review of the literature. Cancer 1975;35:1184–1202.
Bercovici J-P, Nahoul K, Tater D, Charles J-F, Scholler R. Hormonal profile of Leydig cell tumors with gynecomastia. J Clin Endocrinol Metab 1984;59:625–630.
Gabrilove JL, Sharma DC, Wotiz HH, Dorman RI. Feminizing adrenocortical tumors in the male: a review of 52 cases including a case report. Medicine 1965;44:37–79.
Boyar RM, Nogeire C, Fukushima D, Hellman L, Fishman J. Studies of the diurnal pattern of plasma corticosteroids and gonadotropins in two cases of feminizing adrenal carcinoma: measurements of estrogen and corticosteroid production. J Clin Endocrinol Metab 1977;44:39–45.
Kirschner MA, Cohen FB, Jespersen D. Estrogen production and its origin in men with gonadotropin-producing neoplasms. J Clin Endocrinol Metab 1974;39:112–118.
Baker HWG, Burger HG, DeKretser DM, Dolmanis A, Hudson B, O’Connor S, et al. A study of the endocrine manifestations of hepatic cirrhosis. Q J Med 1976;45:145–178.
Cavanaugh J, Niewoehner CB, Nuttall FQ. Gynecomastia and cirrhosis of the liver. Arch Intern Med 1990;150:563–565.
Van Thiel DH. Ethanol: its adverse effects upon the hypothalamic-pituitary-gonadal axis. J Lab Clin Med 1983;101:21–33.
Kley HK, Niederau C, Stremmel W, Lax R, Strohmeyer G, Kruskemper HL. Conversion of androgens to estrogens in idiopathic hemochromatosis: comparison with alcoholic liver cirrhosis. J Clin Endocrinol Metab 1985;61:1–6.
Gavaler JS, Rosenblum ER, Van Thiel DH, Eagon PK, Pohl CR, Campbell IM, Gavaler J. Biologically active phytoestrogens are present in bourbon. Alcohol Clin Exp Res 1987; 11:399–406.
Chopra I J, Tulchinsky D. Status of estrogen-androgen balance in hyperthyroid men with Graves’ disease. J Clin Endocrinol Metab 1974;38:269–277.
Southren AL, Olive J, Gordon GG, Vittek J, Brener J, Rafii F. The conversion of androgens to estrogens in hyperthyroidism. J Clin Endocrinol Metab 1974;38:207–214.
Ashkar FS, Smoak WM, Gilson AJ, Miller R. Gynecomastia and mastoplasia in Graves’ disease. Metabolism 1970;19:946–951.
Klatskin G, Satter WT, Humm FD. Gynecomastia due to malnutrition. I. Clinical studies. Am J Med Sci 1947;213:19–30.
Linn S, Almagor G, Lamm S. Gynecomastia among Ethiopian Jews. Pub Hlth Rep 1986; 101:237.
Semple CG, Gray CE, Beastall GH. Male hypogonadism-a non-specific consequence of illness. Q J Med 1987;64:601–607.
Anderson KE, Rosner W, Khan MS, New MI, Pang S, Wissel PS, Kappas A. Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and Cortisol and their respective binding globulins in man. Life Sci 1987;40:1761–1768.
Schmitt GW, Shehadeh I, Sawin CT. Transient gynecomastia in chronic renal failure during chronic intermittent hemodialysis. Ann Intern Med 1968;69:73–79.
Morley JE. Melmed S. Gonadal dysfunction in systemic disorders. Metabolism 1979;28:1051–1073.
Rifka SM, Pita JC, Loriaux DL. Mechanism of interaction of digitalis with estradiol binding sites in rat uteri. Endocrinology 1976;99:1091–1096.
Swerdloff RS, Palacios A, McClure RD, Campfield LA, Brosman, SS. Male contraception: clinical assessment of chronic administration of testosterone enanthate. Int J Androl 2(Suppl):731–747.
McCullagh EP, Rossmiller HR. Methyl testosterone. I. Androgenic effects and the production of gynecomastia and oligospermia. J Clin Endocrinol Metab 1941;1:496–502.
Saeter G, Fossa SD, Norman N. Gynaecomastia folllowing cytotoxic therapy for testicular cancer. Br J Urol 1987;59:348–352.
Rose LI, Underwood RH, Newmark SR, Kisch ES, Williams GH. Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 1977;87:398–403.
Pont A, Goldman ES, Sugar AM, Siiteri PK, Stevens DA. Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia. Arch Intern Med 1985;145:1429–1431.
Fagan TC, Johnson DG, Grosso DS. Metronidazole-induced gynecomastia. JAMA 1985;254:3217.
Loriaux DL, Menard R, Taylor A, Pita JC, Santen R. Spironolactone and endocrine dysfunction. Ann Intern Med 1976;85:630–636.
Winters S J, Lee J, Troen P. Competition of the histamine H2 antagonist cimetidine for androgen binding sites in man. J Androl 1980;1:111–114.
Boccon-Gibod L, Fournier G, Bottet P, Marechal JM, Guiter J. Rischman P, et al. Flutamide versus orchiectomy in the treatment of metastatic prostate carcinoma. Eur Urol 1997;32:391–396.
Purohit V, Ahluwahlia BS, Vigersky RA. Marihuana inhibits dihydrotestosterone binding to the andro-gen receptor. Endocrinology 1980;107:848–850.
Tanner LA, Bosco LA. Gynecomastia associated with calcium channel blocker therapy. Arch Intern Med 1988;148:379–380.
Cohn L, Feller AG, Draper MW, Rudman IW, Rudman D. Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF-I concentrations. Clin Endocrinol (Oxford) 1993;39:417–425.
Lilleng R, Paksoy N, Vural G, Langmark F, Hagmar B. Assessment of fine-needle aspiration cytology and histopathology for diagnosing male breast masses. Acta Cytol 1995;39:877–881.
McDermott MT, Hofeldt FD, Kidd GS. Tamoxifen therapy for painful idiopathic gynecomastia. South Med J 1990;83:1283–1285.
Buckle R. Danazol in the treatment of gynecomastia. Drugs 1980;19:356–361.
Zachmann M, Eiholzer U, Muritano M, Werder EA, Manella B. Treatment of pubertal gynecomastia with testolactone. Acta Endocrinol 1986;113(Suppl 279):218–226.
Fass D, Steinfeld A, Brown J, Tessler A. Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequelae. Int J Radiat Oncol Biol Phys 1986; 12:407–08.
Rosenberg GJ. Gynecomastia: suction lipectomy as a contemporary solution. Plast Reconst Surg 1987; 80:379–385.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Carlson, H.E. (2000). Gynecomastia. In: Morley, J.E., van den Berg, L. (eds) Endocrinology of Aging. Contemporary Endocrinology, vol 20. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-715-4_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-715-4_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-171-4
Online ISBN: 978-1-59259-715-4
eBook Packages: Springer Book Archive